Skip to main content
. 2021 Dec 8;10(12):1587. doi: 10.3390/pathogens10121587

Figure 1.

Figure 1

Overall pretreatment drug resistance levels in Mexico City, 2017–2020. Classified by (a) drug class, (b) individual drug. PDR was estimated from 6688 protease-reverse transcriptase and 6709 integrase sequences using the Stanford HIVdb tool (v9.0). Individuals with HIV PDR were defined as those having a score ≥15 to any of the drugs in the corresponding category, as defined in the Methods. Error bars represent 95% confidence intervals. Comparisons were made with Fisher’s exact test. PDR, pretreatment drug resistance; PI, protease inhibitor; RTI, reverse transcriptase inhibitor; NRTI, nucleoside reverse transcriptase inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor; INSTI, integrase strand-transfer inhibitor; EFV, efavirenz; NVP, nevirapine; ATV/r, atazanavir/ritonavir; DRV/r, darunavir/ritonavir; LPV/r, lopinavir/ritonavir; EVG, elvitegravir; RAL, raltegravir; BIC, bictegravir; CAB, cabotegravir; DTG, dolutegravir.